Results 181 to 190 of about 84,070 (269)

Investigator‐Led Research to Improve the Diagnostic Assessment of Platelet Function Disorders: Reflections on the Challenges and Rewards

International Journal of Laboratory Hematology, Volume 48, Issue 4, Page 721-731, August 2026.
ABSTRACT Introduction Investigator‐led research and quality improvement initiatives have led to important improvements in the diagnostic assessment of platelet function disorders (PFD). Methods Personal reflections were used to summarize our contributions to knowledge on PFD diagnostic assessment, pathogenesis, and bleeding risks.
Catherine P. M. Hayward
wiley   +1 more source

Evaluation of a Point‐of‐Care Viscoelastic Coagulation Monitor (VCM Vet) and Thromboelastography (TEG) in Bonobos (Pan paniscus)

Journal of Medical Primatology, Volume 55, Issue 4, August 2026.
ABSTRACT Introduction Bonobos (Pan paniscus) are endangered and uncommon in managed care. Prothrombotic and hypofibrinolytic states are encountered with cardiovascular disease, ischemic stroke, and neoplasia. Materials and Methods Twelve bonobos from one institution were evaluated during anesthetized exams.
Megan M. Roeder, Priya Bapodra‐Villaverde, Lauren E. Mumm, Alex M. Lynch, Laura R. Culbreth, Megan L. Cabot, Timothy A. Georoff, Larry J. Minter   +7 more
wiley   +1 more source

A prolonged activated partial thromboplastin time indicates poor short-term prognosis in patients with hepatic encephalopathy: insights from the MIMIC database. [PDF]

Front Med (Lausanne)
Zhan L, Yang Y, Nie B, Kou Y, Du S, Tian Y, Huang Y, Ye R, Huang Z, Luo B, Ge L, Ye S.   +11 more
europepmc   +1 more source

Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation. [PDF]

Clin Appl Thromb Hemost
Burša F, Frelich M, Sklienka P, Němcová S, Kučerová Z, Jor O, Romanová T, Kondé A, Janošek J, Sagan J, Máca J.   +10 more
europepmc   +1 more source

A retrospective study of the prevalence of isolated prolongation of activated partial thromboplastin time in the preoperative setting. [PDF]

JA Clin Rep
Watanabe Y, Kato Y, Matsuno T.
europepmc   +1 more source

Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.

American Journal of Clinical Pathology, 2013
C. Takemoto, M. Streiff, K. Shermock, P. Kraus, Junnan Chen, Jayesh T. Jani, T. Kickler   +6 more
semanticscholar   +1 more source

The evaluation of prothrombin time and activated partial thromboplastin time among diabetic and healthy controls in Africa: systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Getu F, Alemayehu E, Tesfaye A, Genanew B, Walle M.   +4 more
europepmc   +1 more source

INTERNATIONAL NORMALIZED RATIO AND ACTIVATED PARTIAL THROMBOPLASTIN TIME DO NOT PREDICT PLASMA TRANSFUSION IN LIVER TRANSPLANTATION. [PDF]

Arq Bras Cir Dig
Marinho DS, Rocha Filho JA, Figueira ERR, Fernandes CR, Detsch Junior RC, Garcia JHP, Andraus W, D'Albuquerque LAC.   +7 more
europepmc   +1 more source

Activated partial thromboplastin time-based clot waveform analysis: a potential for application in acute myocardial infarction and its complications. [PDF]

Sci Rep
Ng CL, Uy FM, Cheong MA, Wong WH, Lau YH, Ng HJ, Yeo KK, Tan CW.   +7 more
europepmc   +1 more source